3.19.1 html 176 310 1 false 70 0 false 8 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://miragentherapeutics.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://miragentherapeutics.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 1001001 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://miragentherapeutics.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://miragentherapeutics.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Statements 4 false false R5.htm 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://miragentherapeutics.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Statements 5 false false R6.htm 1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://miragentherapeutics.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 2101100 - Disclosure - Description of Business Sheet http://miragentherapeutics.com/role/DescriptionOfBusiness Description of Business Notes 7 false false R8.htm 2102100 - Disclosure - Summary of Significant Accounting Policies Sheet http://miragentherapeutics.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 2103100 - Disclosure - Strategic Alliance and Collaboration with Servier Sheet http://miragentherapeutics.com/role/StrategicAllianceAndCollaborationWithServier Strategic Alliance and Collaboration with Servier Notes 9 false false R10.htm 2104100 - Disclosure - Reverse Merger Sheet http://miragentherapeutics.com/role/ReverseMerger Reverse Merger Notes 10 false false R11.htm 2105100 - Disclosure - Property and Equipment Sheet http://miragentherapeutics.com/role/PropertyAndEquipment Property and Equipment Notes 11 false false R12.htm 2106100 - Disclosure - Accrued Liabilities Sheet http://miragentherapeutics.com/role/AccruedLiabilities Accrued Liabilities Notes 12 false false R13.htm 2107100 - Disclosure - Notes Payable Notes http://miragentherapeutics.com/role/NotesPayable Notes Payable Notes 13 false false R14.htm 2108100 - Disclosure - Commitments and Contingencies Sheet http://miragentherapeutics.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 14 false false R15.htm 2109100 - Disclosure - Capital Stock Sheet http://miragentherapeutics.com/role/CapitalStock Capital Stock Notes 15 false false R16.htm 2110100 - Disclosure - Warrants Sheet http://miragentherapeutics.com/role/Warrants Warrants Notes 16 false false R17.htm 2111100 - Disclosure - Share-Based Compensation Sheet http://miragentherapeutics.com/role/ShareBasedCompensation Share-Based Compensation Notes 17 false false R18.htm 2112100 - Disclosure - Income Taxes Sheet http://miragentherapeutics.com/role/IncomeTaxes Income Taxes Notes 18 false false R19.htm 2113100 - Disclosure - Net Loss Per Share Sheet http://miragentherapeutics.com/role/NetLossPerShare Net Loss Per Share Notes 19 false false R20.htm 2114100 - Disclosure - Selected Quarterly Financial Data (Unaudited) Sheet http://miragentherapeutics.com/role/SelectedQuarterlyFinancialDataUnaudited Selected Quarterly Financial Data (Unaudited) Notes 20 false false R21.htm 2115100 - Disclosure - Subsequent Events Sheet http://miragentherapeutics.com/role/SubsequentEvents Subsequent Events Notes 21 false false R22.htm 2202201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://miragentherapeutics.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://miragentherapeutics.com/role/SummaryOfSignificantAccountingPolicies 22 false false R23.htm 2302302 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://miragentherapeutics.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://miragentherapeutics.com/role/SummaryOfSignificantAccountingPolicies 23 false false R24.htm 2303301 - Disclosure - Strategic Alliance and Collaboration with Servier (Tables) Sheet http://miragentherapeutics.com/role/StrategicAllianceAndCollaborationWithServierTables Strategic Alliance and Collaboration with Servier (Tables) Tables http://miragentherapeutics.com/role/StrategicAllianceAndCollaborationWithServier 24 false false R25.htm 2304301 - Disclosure - Reverse Merger (Tables) Sheet http://miragentherapeutics.com/role/ReverseMergerTables Reverse Merger (Tables) Tables http://miragentherapeutics.com/role/ReverseMerger 25 false false R26.htm 2305301 - Disclosure - Property and Equipment (Tables) Sheet http://miragentherapeutics.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://miragentherapeutics.com/role/PropertyAndEquipment 26 false false R27.htm 2306301 - Disclosure - Accrued Liabilities (Tables) Sheet http://miragentherapeutics.com/role/AccruedLiabilitiesTables Accrued Liabilities (Tables) Tables http://miragentherapeutics.com/role/AccruedLiabilities 27 false false R28.htm 2307301 - Disclosure - Notes Payable (Tables) Notes http://miragentherapeutics.com/role/NotesPayableTables Notes Payable (Tables) Tables http://miragentherapeutics.com/role/NotesPayable 28 false false R29.htm 2308301 - Disclosure - Commitments and Contingencies (Tables) Sheet http://miragentherapeutics.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://miragentherapeutics.com/role/CommitmentsAndContingencies 29 false false R30.htm 2309301 - Disclosure - Capital Stock (Tables) Sheet http://miragentherapeutics.com/role/CapitalStockTables Capital Stock (Tables) Tables http://miragentherapeutics.com/role/CapitalStock 30 false false R31.htm 2310301 - Disclosure - Warrants (Tables) Sheet http://miragentherapeutics.com/role/WarrantsTables Warrants (Tables) Tables http://miragentherapeutics.com/role/Warrants 31 false false R32.htm 2311301 - Disclosure - Share-Based Compensation (Tables) Sheet http://miragentherapeutics.com/role/ShareBasedCompensationTables Share-Based Compensation (Tables) Tables http://miragentherapeutics.com/role/ShareBasedCompensation 32 false false R33.htm 2312301 - Disclosure - Income Taxes (Tables) Sheet http://miragentherapeutics.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://miragentherapeutics.com/role/IncomeTaxes 33 false false R34.htm 2313301 - Disclosure - Net Loss Per Share (Tables) Sheet http://miragentherapeutics.com/role/NetLossPerShareTables Net Loss Per Share (Tables) Tables http://miragentherapeutics.com/role/NetLossPerShare 34 false false R35.htm 2314301 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Tables) Sheet http://miragentherapeutics.com/role/SelectedQuarterlyFinancialDataUnauditedTables Selected Quarterly Financial Data (Unaudited) (Tables) Tables http://miragentherapeutics.com/role/SelectedQuarterlyFinancialDataUnaudited 35 false false R36.htm 2401401 - Disclosure - Description of Business - Narrative (Details) Sheet http://miragentherapeutics.com/role/DescriptionOfBusinessNarrativeDetails Description of Business - Narrative (Details) Details 36 false false R37.htm 2402403 - Disclosure - Summary of Significant Accounting Policies - Assets and Liabilities Measured on a Recurring Basis (Details) Sheet http://miragentherapeutics.com/role/SummaryOfSignificantAccountingPoliciesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails Summary of Significant Accounting Policies - Assets and Liabilities Measured on a Recurring Basis (Details) Details 37 false false R38.htm 2402405 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) Sheet http://miragentherapeutics.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails Summary of Significant Accounting Policies - Narrative (Details) Details 38 false false R39.htm 2403402 - Disclosure - Strategic Alliance and Collaboration with Servier - Collaboration Revenues (Details) Sheet http://miragentherapeutics.com/role/StrategicAllianceAndCollaborationWithServierCollaborationRevenuesDetails Strategic Alliance and Collaboration with Servier - Collaboration Revenues (Details) Details 39 false false R40.htm 2403403 - Disclosure - Strategic Alliance and Collaboration with Servier - Narrative (Details) Sheet http://miragentherapeutics.com/role/StrategicAllianceAndCollaborationWithServierNarrativeDetails Strategic Alliance and Collaboration with Servier - Narrative (Details) Details http://miragentherapeutics.com/role/StrategicAllianceAndCollaborationWithServierTables 40 false false R41.htm 2404402 - Disclosure - Reverse Merger - Narrative (Details) Sheet http://miragentherapeutics.com/role/ReverseMergerNarrativeDetails Reverse Merger - Narrative (Details) Details 41 false false R42.htm 2404403 - Disclosure - Reverse Merger - Summary of Assets Acquired and Liabilities Assumed (Details) Sheet http://miragentherapeutics.com/role/ReverseMergerSummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails Reverse Merger - Summary of Assets Acquired and Liabilities Assumed (Details) Details 42 false false R43.htm 2405402 - Disclosure - Property and Equipment - Components of Property and Equipment (Details) Sheet http://miragentherapeutics.com/role/PropertyAndEquipmentComponentsOfPropertyAndEquipmentDetails Property and Equipment - Components of Property and Equipment (Details) Details 43 false false R44.htm 2405403 - Disclosure - Property and Equipment - Narrative (Details) Sheet http://miragentherapeutics.com/role/PropertyAndEquipmentNarrativeDetails Property and Equipment - Narrative (Details) Details 44 false false R45.htm 2406402 - Disclosure - Accrued Liabilities - Components of Accrued Liabilities (Details) Sheet http://miragentherapeutics.com/role/AccruedLiabilitiesComponentsOfAccruedLiabilitiesDetails Accrued Liabilities - Components of Accrued Liabilities (Details) Details 45 false false R46.htm 2407402 - Disclosure - Notes Payable - Narrative (Details) Notes http://miragentherapeutics.com/role/NotesPayableNarrativeDetails Notes Payable - Narrative (Details) Details 46 false false R47.htm 2407403 - Disclosure - Notes Payable - Composition of Notes Payable (Details) Notes http://miragentherapeutics.com/role/NotesPayableCompositionOfNotesPayableDetails Notes Payable - Composition of Notes Payable (Details) Details 47 false false R48.htm 2407404 - Disclosure - Notes Payable - Future Annual Minimum Principal Payments (Details) Notes http://miragentherapeutics.com/role/NotesPayableFutureAnnualMinimumPrincipalPaymentsDetails Notes Payable - Future Annual Minimum Principal Payments (Details) Details 48 false false R49.htm 2408402 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://miragentherapeutics.com/role/CommitmentsAndContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 49 false false R50.htm 2408403 - Disclosure - Commitments and Contingencies - Future Minimum Rental Payments (Details) Sheet http://miragentherapeutics.com/role/CommitmentsAndContingenciesFutureMinimumRentalPaymentsDetails Commitments and Contingencies - Future Minimum Rental Payments (Details) Details 50 false false R51.htm 2409402 - Disclosure - Capital Stock - Narrative (Details) Sheet http://miragentherapeutics.com/role/CapitalStockNarrativeDetails Capital Stock - Narrative (Details) Details 51 false false R52.htm 2409403 - Disclosure - Capital Stock - Summary of Series Preferred Stock (Details) Sheet http://miragentherapeutics.com/role/CapitalStockSummaryOfSeriesPreferredStockDetails Capital Stock - Summary of Series Preferred Stock (Details) Details 52 false false R53.htm 2410402 - Disclosure - Warrants - Stock Warrant Activity (Details) Sheet http://miragentherapeutics.com/role/WarrantsStockWarrantActivityDetails Warrants - Stock Warrant Activity (Details) Details 53 false false R54.htm 2410403 - Disclosure - Warrants - Stock Warrants Outstanding (Details) Sheet http://miragentherapeutics.com/role/WarrantsStockWarrantsOutstandingDetails Warrants - Stock Warrants Outstanding (Details) Details 54 false false R55.htm 2410404 - Disclosure - Warrants - Narrative (Details) Sheet http://miragentherapeutics.com/role/WarrantsNarrativeDetails Warrants - Narrative (Details) Details 55 false false R56.htm 2411402 - Disclosure - Share-Based Compensation - Narrative (Details) Sheet http://miragentherapeutics.com/role/ShareBasedCompensationNarrativeDetails Share-Based Compensation - Narrative (Details) Details 56 false false R57.htm 2411403 - Disclosure - Share-Based Compensation - Stock Option Activity (Details) Sheet http://miragentherapeutics.com/role/ShareBasedCompensationStockOptionActivityDetails Share-Based Compensation - Stock Option Activity (Details) Details 57 false false R58.htm 2411404 - Disclosure - Share-Based Compensation - Fair Value Assumption for Stock Options (Details) Sheet http://miragentherapeutics.com/role/ShareBasedCompensationFairValueAssumptionForStockOptionsDetails Share-Based Compensation - Fair Value Assumption for Stock Options (Details) Details 58 false false R59.htm 2411405 - Disclosure - Share-Based Compensation - Allocation of Share-based Compensation Expense on Statements of Operations (Details) Sheet http://miragentherapeutics.com/role/ShareBasedCompensationAllocationOfShareBasedCompensationExpenseOnStatementsOfOperationsDetails Share-Based Compensation - Allocation of Share-based Compensation Expense on Statements of Operations (Details) Details 59 false false R60.htm 2412402 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details) Sheet http://miragentherapeutics.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails Income Taxes - Effective Tax Rate Reconciliation (Details) Details 60 false false R61.htm 2412403 - Disclosure - Income Taxes - Components of Deferred Tax Assets (Details) Sheet http://miragentherapeutics.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsDetails Income Taxes - Components of Deferred Tax Assets (Details) Details 61 false false R62.htm 2412404 - Disclosure - Income Taxes - Narrative (Details) Sheet http://miragentherapeutics.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 62 false false R63.htm 2413402 - Disclosure - Net Loss Per Share - Summary of Potential Dilutive Securities (Details) Sheet http://miragentherapeutics.com/role/NetLossPerShareSummaryOfPotentialDilutiveSecuritiesDetails Net Loss Per Share - Summary of Potential Dilutive Securities (Details) Details 63 false false R64.htm 2413403 - Disclosure - Net Loss Per Share - Narrative (Details) Sheet http://miragentherapeutics.com/role/NetLossPerShareNarrativeDetails Net Loss Per Share - Narrative (Details) Details 64 false false R65.htm 2414402 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Details) Sheet http://miragentherapeutics.com/role/SelectedQuarterlyFinancialDataUnauditedDetails Selected Quarterly Financial Data (Unaudited) (Details) Details http://miragentherapeutics.com/role/SelectedQuarterlyFinancialDataUnauditedTables 65 false false All Reports Book All Reports mgen-20181231.xml mgen-20181231.xsd mgen-20181231_cal.xml mgen-20181231_def.xml mgen-20181231_lab.xml mgen-20181231_pre.xml http://xbrl.sec.gov/country/2017-01-31 http://fasb.org/srt/2018-01-31 http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 true true